 | | | | Novavax Inc (NVAX.O)said on Friday its COVID-19 vaccine candidate showed immune response and protection against the SARS-CoV-2 Beta variant, which was originally identified in South Africa, in three animal and human studies. | | | | | | The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. | | | | | | British Prime Minister Boris Johnson is set to delay lockdown lifting to July 19 after cases of the Delta variant, first identified in India, rose in the country, The Sun reported on Friday. | | | | | | The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. | | | | | | France reported 3,871 new confirmed coronavirus cases on Friday, the second day in a row that the new cases tally was below 5,000 and the first time since late August 2020 that the seven-day moving average of new cases fell below 5,000. | | | | | | Cruise operator Royal Caribbean (RCL.N) said on Thursday two guests onboard its Celebrity Millennium ship have tested positive for COVID-19, but are asymptomatic and currently in isolation. | | | | | | Denmark is ready to deliver 500,000 COVID-19 vaccine doses to Ukraine, Ukrainian President Volodymyr Zelenskiy's office said in a statement after he spoke to Danish Prime Minister Mette Frederiksen by phone on Friday. | | | | | | British foreign minister Dominic Raab said on Friday there was no doubt some countries were using vaccines as a diplomatic tool to secure influence but Britain did not support so-called vaccine diplomacy. | | | | | | The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had received the shot died from a rare form of blood clotting. | | | | | | The European Union does not expect Johnson & Johnson (JNJ.N) will be able to deliver 55 million COVID-19 vaccine doses it had committed to shipping to the bloc by the end of June, an EU official said on Friday. | | | | | |
